Abstract:Maternal immune system tolerance to the semiallogeneic fetus is essential for a successful pregnancy; however, the mechanisms underlying this immunotolerance have not been fully elucidated. Here, we demonstrate that myeloid-derived suppressor cells play an important role in maintaining feto-maternal tolerance. A significant expansion of granulocytic myeloid-derived suppressor cells was observed in multiple immune organs and decidual tissues from pregnant mice. Pregnancy-derived granulocytic myeloid-derived sup… Show more
“…MDSC have been described widely to play an important role for immune regulation during pathological processes such as tumours, infections or transplant reactions [16,17,21,24,32,33]; recently, however, increasing evidence has emerged revealing that they also control immune adaptation to pregnancy and contribute to maternal-fetal tolerance both maternally and fetally [12][13][14][15]19,34,35]. Until now, little is known about their impact on immune regulation in neonates, and especially in preterm infants.…”
Section: Discussionmentioning
confidence: 99%
“…Before birth, GR-MDSC may play a critical role in maintaining maternal-fetal tolerance [12,13,34,35], being beneficial for fetal life, whereas postnatally elevated GR-MDSC numbers may contribute to postnatal immunosuppression and susceptibility to infections. Before birth, GR-MDSC may play a critical role in maintaining maternal-fetal tolerance [12,13,34,35], being beneficial for fetal life, whereas postnatally elevated GR-MDSC numbers may contribute to postnatal immunosuppression and susceptibility to infections.…”
Section: Gr-mdsc In Preterm Infantsmentioning
confidence: 99%
“…In humans, MDSC can be divided into two subgroups: granulocytic MDSC (GR-MDSC) expressing granulocytic lineage markers CD15 and/or CD66b, and monocytic MDSC (MO-MDSC) expressing the monocytic antigen CD14. GR-MDSC, but not MO-MDSC, accumulate during pregnancy in both mother and fetus [12][13][14][15]19], and are supposed to play a role in mediating maternal-fetal tolerance. A phenotypical difference between GR-MDSC and mature granulocytes is the lower density of GR-MDSC, sedimenting with mononuclear cells (MNC) after density gradient centrifugation.…”
Section: Introductionmentioning
confidence: 99%
“…Potential mechanisms of postnatal immunosuppression are a bias of T helper (Th) cell responses towards Th2 and an accumulation of immunemodulatory cells such as regulatory T cells (T regs ), regulatory B cells (B regs ) and CD71 positive erythroid cells [7,10,11]. Recently, we and others have described myeloidderived suppressor cells (MDSC) as potential immune regulators during pregnancy [12][13][14][15].…”
Preterm delivery is the leading cause of perinatal morbidity and mortality. Among the most important complications in preterm infants are peri- or postnatal infections. Myeloid-derived suppressor cells (MDSC) are myeloid cells with suppressive activity on other immune cells. Emerging evidence suggests that granulocytic MDSC (GR-MDSC) play a pivotal role in mediating maternal-fetal tolerance. The role of MDSC for postnatal immune-regulation in neonates is incompletely understood. Until the present time, nothing was known about expression of MDSC in preterm infants. In the present pilot study, we quantified GR-MDSC counts in cord blood and peripheral blood of preterm infants born between 23â+â0 and 36â+â6 weeks of gestation (WOG) during the first 3 months of life and analysed the effect of perinatal infections. We show that GR-MDSC are increased in cord blood independent of gestational age and remain elevated in peripheral blood of preterm infants during the neonatal period. After day 28 they drop to nearly adult levels. In case of perinatal or postnatal infection, GR-MDSC accumulate further and correlate with inflammatory markers C-reactive protein (CRP) and white blood cell counts (WBC). Our results point towards a role of GR-MDSC for immune-regulation in preterm infants and render them as a potential target for cell-based therapy of infections in these patients.
“…MDSC have been described widely to play an important role for immune regulation during pathological processes such as tumours, infections or transplant reactions [16,17,21,24,32,33]; recently, however, increasing evidence has emerged revealing that they also control immune adaptation to pregnancy and contribute to maternal-fetal tolerance both maternally and fetally [12][13][14][15]19,34,35]. Until now, little is known about their impact on immune regulation in neonates, and especially in preterm infants.…”
Section: Discussionmentioning
confidence: 99%
“…Before birth, GR-MDSC may play a critical role in maintaining maternal-fetal tolerance [12,13,34,35], being beneficial for fetal life, whereas postnatally elevated GR-MDSC numbers may contribute to postnatal immunosuppression and susceptibility to infections. Before birth, GR-MDSC may play a critical role in maintaining maternal-fetal tolerance [12,13,34,35], being beneficial for fetal life, whereas postnatally elevated GR-MDSC numbers may contribute to postnatal immunosuppression and susceptibility to infections.…”
Section: Gr-mdsc In Preterm Infantsmentioning
confidence: 99%
“…In humans, MDSC can be divided into two subgroups: granulocytic MDSC (GR-MDSC) expressing granulocytic lineage markers CD15 and/or CD66b, and monocytic MDSC (MO-MDSC) expressing the monocytic antigen CD14. GR-MDSC, but not MO-MDSC, accumulate during pregnancy in both mother and fetus [12][13][14][15]19], and are supposed to play a role in mediating maternal-fetal tolerance. A phenotypical difference between GR-MDSC and mature granulocytes is the lower density of GR-MDSC, sedimenting with mononuclear cells (MNC) after density gradient centrifugation.…”
Section: Introductionmentioning
confidence: 99%
“…Potential mechanisms of postnatal immunosuppression are a bias of T helper (Th) cell responses towards Th2 and an accumulation of immunemodulatory cells such as regulatory T cells (T regs ), regulatory B cells (B regs ) and CD71 positive erythroid cells [7,10,11]. Recently, we and others have described myeloidderived suppressor cells (MDSC) as potential immune regulators during pregnancy [12][13][14][15].…”
Preterm delivery is the leading cause of perinatal morbidity and mortality. Among the most important complications in preterm infants are peri- or postnatal infections. Myeloid-derived suppressor cells (MDSC) are myeloid cells with suppressive activity on other immune cells. Emerging evidence suggests that granulocytic MDSC (GR-MDSC) play a pivotal role in mediating maternal-fetal tolerance. The role of MDSC for postnatal immune-regulation in neonates is incompletely understood. Until the present time, nothing was known about expression of MDSC in preterm infants. In the present pilot study, we quantified GR-MDSC counts in cord blood and peripheral blood of preterm infants born between 23â+â0 and 36â+â6 weeks of gestation (WOG) during the first 3 months of life and analysed the effect of perinatal infections. We show that GR-MDSC are increased in cord blood independent of gestational age and remain elevated in peripheral blood of preterm infants during the neonatal period. After day 28 they drop to nearly adult levels. In case of perinatal or postnatal infection, GR-MDSC accumulate further and correlate with inflammatory markers C-reactive protein (CRP) and white blood cell counts (WBC). Our results point towards a role of GR-MDSC for immune-regulation in preterm infants and render them as a potential target for cell-based therapy of infections in these patients.
“…cancer, infectious diseases, autoimmunity, and obesity) [57] (Box 2 and section on Neutrophil Diversity and Heterogeneity in Cancer). During mouse pregnancy, they are increased in the circulation of pregnant females relative to non-pregnant females, migrate to the uterus, and can drive CD4 + and CD8 + T cell suppression, thus permitting embryo implantation and successful pregnancy; indeed, depletion of these neutrophils using anti-Gr-1 antibodies caused CD3 + T cell infiltration in the uterus and resorption of the conceived embryo [58,59]. Mechanistically, such T cell suppression by PMN-MDSCs was reported to be driven by downregulation of L-selectin (CD62L) Box…”
Objectives. Recombinant granulocyte colony-stimulating factor (G-CSF) is frequently administered to patients with cancer to enhance granulocyte recovery post-chemotherapy. Clinical trials have also used G-CSF to modulate myeloid cell function in pregnancy and inflammatory diseases. Although the contribution of G-CSF to expanding normal granulocytes is well known, the effect of this cytokine on the phenotype and function of immunosuppressive granulocytic cells remains unclear. Here, we investigate the impact of physiological and iatrogenic G-CSF on an as yet undescribed granulocyte phenotype and ensuing outcome on T cells in the settings of cancer and pregnancy. Methods. Granulocytes from patients treated with recombinant G-CSF, patients with late-stage cancer and women enrolled on a trial of recombinant G-CSF were phenotyped by flow cytometry. The ability and mechanism of polarised granulocytes to suppress T-cell proliferation were assessed by cell proliferation assays, flow cytometry and ELISA. Results. We observed that G-CSF leads to a significant upregulation of CD14 expression on CD15 + granulocytes. These CD15 + CD14 + cells are identified in the blood of patients with patients undergoing neutrophil mobilisation with recombinant G-CSF, and physiologically in women early in pregnancy or in those treated as a part of a clinical trial. Immunohistochemistry of tumor tissue or placental tissue identified the expression of G-CSF. The G-CSF upregulates the release of reactive oxygen species (ROS) in CD15 + CD14 + cells leading to the suppression of T-cell proliferation. Conclusions. G-CSF induces a population of ROS + immunosuppressive CD15 + CD14 + granulocytes. Strategies for how recombinant G-CSF
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citationsâcitations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.